Announcements Trials

Browse Landscape

Sponsor

Conditions

Carcinoma, Renal Cell 4 Neoplasms 2 Kidney Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thoracic Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Pleural Neoplasms 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Pleural Diseases 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Lung Neoplasms 1 Lung Diseases 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Gastro Intestinal Stromal Tumor 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma, Bronchogenic 1

Interventions

Imatinib Mesylate 5 nilotinib 4 bosutinib 3 asciminib 2 peginterferon alfa-2a 1 fludarabine phosphate 1 fludarabine 1 Magnetic Resonance Imaging 1 Electrocardiography 1 Echocardiography 1 Diphenhydramine 1 Dasatinib 1 Cyclophosphamide 1 Blood Component Removal 1 Antiemetics 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Philadelphia Chromosome × Tyrosine Kinase Inhibitors × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡